General Atlantic LLC Adagene Inc. Transaction History
General Atlantic LLC
- $2.87 Billion
- Q2 2025
A detailed history of General Atlantic LLC transactions in Adagene Inc. stock. As of the latest transaction made, General Atlantic LLC holds 3,825,952 shares of ADAG stock, worth $7.31 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,825,952
Previous 3,825,952
-0.0%
Holding current value
$7.31 Million
Previous $5.82 Million
28.29%
% of portfolio
0.26%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding ADAG
# of Institutions
13Shares Held
9.65MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.61 Million46.44% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.57 Million0.16% of portfolio
-
Mill Creek Capital Advisors, LLC Conshohocken, PA200KShares$381,2550.01% of portfolio
-
Kamunting Street Capital Management, L.P. Miami Beach, FL126KShares$240,7210.22% of portfolio
-
Morgan Stanley New York, NY77.2KShares$147,5240.0% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $82.9M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...